Tigecycline Injection, Powder, Lyophilized, For Solution
Product Images NDC 55150-228

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tigecycline (NDC 55150-228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (50 mg per vial)

Tigecycline is an intravenous antibiotic medication used to treat certain bacterial infections. Each vial contains 50 mg of tigecycline and 100 mg of lactose. The solution after reconstitution should be yellow to orange in color. The medication is distributed by AuroMedics Pharma LLC and is manufactured in India. This medication requires a prescription and should only be administered intravenously.*

FDA Label Image

Package Label-principal Display Panel (50 mg per vial)

The text is not readable and appears to be a mix of random characters and symbols.*

FDA Label Image

Tigecycline Chemical Structure (Tigecycline Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.